Results 1 to 10 of about 645 (152)

Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment [PDF]

open access: yesAntibiotics, 2023
Among the pathogenic free-living amoebae (FLA), Naegleria fowleri is the etiological agent of a fatal disease known as primary amoebic meningoencephalitis (PAM).
JOSÉ E Piñero   +2 more
exaly   +6 more sources

Nitroxoline is a novel inhibitor of NLRP3-dependent pyroptosis [PDF]

open access: yesCell Death Discovery
Aberrant activity of the NLR family pyrin domain containing 3 (NLRP3) inflammasome contributes to a wide range of diseases associated with acute inflammatory responses and chronic sterile inflammation.
Christina Maeder   +7 more
doaj   +4 more sources

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond

open access: yesAntibiotics, 2022
In the era of escalating antimicrobial resistance, the need for antibacterial drugs with novel or improved modes of action (MOAs) is a health concern of utmost importance.
Mirna Petković Didović   +2 more
exaly   +7 more sources

Contrasting In Vitro Activity of Nitroxoline Against Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae Isolates from Outpatients [PDF]

open access: yesAntibiotics
Background/Objectives: Antimicrobial resistance is a major public health concern, particularly among multidrug-resistant (MDR) Enterobacterales. Nitroxoline is an older antibiotic with a unique mechanism of action that has not been widely used in recent ...
Dominik Maleš   +3 more
doaj   +2 more sources

Synergistic Antimicrobial and Antibiofilm Activity of Nitroxoline in Combination with Hydroquinone Against Uropathogenic Enterococcus faecalis [PDF]

open access: yesAntibiotics
Background: Enterococcus faecalis is a major cause of complicated urinary tract infections (UTIs), characterized by intrinsic resistance and pronounced biofilm formation.
Davorka Repac Antić   +4 more
doaj   +2 more sources

Nitroxoline evidence amoebicidal activity against Acanthamoeba castellanii through DNA damage and the stress response pathways [PDF]

open access: yesInternational Journal for Parasitology: Drugs and Drug Resistance
Acanthamoeba castellanii is a widespread unicellular eukaryote found in diverse environments, including tap water, soil, and swimming pools. It is responsible for severe infections, such as Acanthamoeba keratitis and granulomatous amebic encephalitis ...
Lijun Chen   +5 more
doaj   +2 more sources

Induction of Programmed Cell Death in Acanthamoeba culbertsoni by the Repurposed Compound Nitroxoline [PDF]

open access: yesAntioxidants, 2023
Acanthamoeba is a ubiquitous genus of amoebae that can act as opportunistic parasites in both humans and animals, causing a variety of ocular, nervous and dermal pathologies.
Rubén L. Rodríguez-Expósito   +7 more
doaj   +2 more sources

Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound [PDF]

open access: yesPharmaceuticals
Background/Objectives: Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, remains a major neglected tropical disease, with over six million cases concentrated, primarily in Latin America.
Carlos J. Bethencourt-Estrella   +6 more
doaj   +2 more sources

Disseminated Acanthamoeba Infection with Necrotic Skin Lesions and Granulomatous Vasculitis, United States [PDF]

open access: yesEmerging Infectious Diseases
An elderly man, on dupilumab therapy for asthma and sinus polyposis, sought care for necrotic skin lesions. Biopsy revealed granulomatous vasculitis and he received immunosuppressive therapy but worsened.
Maria Koshy   +5 more
doaj   +2 more sources

Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteria [PDF]

open access: yesNature Communications
Nitroxoline is a bacteriostatic quinoline antibiotic, known to form complexes with metals. Its clinical indications are limited to uncomplicated urinary tract infections, with a susceptibility breakpoint only available for Escherichia coli. Here, we test
Elisabetta Cacace   +20 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy